Lv5
880 积分 2021-02-23 加入
Quality risk management and data integrity in R&D laboratories supporting CMC lifecycle of biological products
13天前
已完结
Impact of antioxidant excipients on N-nitrosamine formation and bioequivalence in metformin formulations (review article)
21天前
已关闭
Development of a sensitive LC-MS/MS method for simultaneous determination of three nitrosamines in losartan API and assessment of nitrosamines formation
1个月前
已完结
Impact of antioxidant excipients on N-nitrosamine formation and bioequivalence in metformin formulations (review article)
1个月前
已关闭
The Presence of Nitrosamines and Nitrosamine Drug-Related Substances in Pharmaceutical Products: An Overview of Regulatory Concerns, Analytical Methodologies, and Control Strategies
1个月前
已完结
Risk assessment and management strategy of two new NDSRIs in a pharmaceutical drug product for the treatment of a rare disease: From prediction to control
1个月前
已完结
Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches
1个月前
已完结
Evaluation of the nitrosamine impurities of ACE inhibitors using computational, in vitro, and in vivo methods demonstrate no genotoxic potential
1个月前
已完结
Analytical Procedure Development and Proposed Established Conditions: A Case Study of a Mass Spectrometry Based NDSRI Analytical Procedure
1个月前
已完结
Modified NAP test: A simple and Responsive Nitrosating Methodology for Risk Evaluation of NDSRIs
1个月前
已完结
皖公网安备34019202002308
